What does Singular Genomics Systems, Inc. do?

Jun 22 2025 06:58 PM IST
share
Share Via
Singular Genomics Systems, Inc. is a micro-cap company in the Medical Specialties industry, reporting net sales of $0 million and a net loss of $17 million as of September 2024. Key metrics include a market cap of $50.77 million and a negative return on equity of -70.04%.
Overview:
Singular Genomics Systems, Inc. operates in the Medical Specialties industry and is categorized as a micro-cap company.

Financial Snapshot:
Most recent Net Sales: 0 Million (Quarterly Results - Sep 2024)
Most recent Net Profit: -17 Million (Quarterly Results - Sep 2024)
Market-cap: USD 50.77 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 2,919.01%
Debt Equity: -0.80
Return on Equity: -70.04%
Price to Book: 0.41

Contact Details:
Details: No Company Details Available
Registrar Address: Not available.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News